A complete application in a minute — tailored resume and cover letter, ready to send.
MoonLake Immunotherapeutics in the United States seeks a National Sales Director to build and lead the field sales organization for the potential launch of sonelokimab in hidradenitis suppurativa, subject to regulatory approval.
The role requires a track record in specialty pharma, leading teams, and delivering launches, with close cross-functional collaboration across commercial functions to accelerate learning and ensure compliant execution.
The National Sales Director will build and lead MoonLake's U.S. field sales organization for the potential launch of sonelokimab in hidradenitis suppurativa (HS), subject to regulatory approval.
The National Sales Director will build and lead MoonLake's U.S. field sales organization for the potential launch of sonelokimab in hidradenitis suppurativa (HS), subject to regulatory approval.
This founding commercial leadership role is accountable for translating enterprise and brand priorities into disciplined field execution, recruiting and developing high-performing leaders and sellers, establishing performance standards, and creating a consistent national culture built for launch.
The role will partner closely across Commercial, Market Access, Field Reimbursement, Medical Affairs, Patient Services, Analytics, Training, and Legal/Compliance to remove launch friction, accelerate learning, and adapt execution as market conditions evolve.
An exciting job opportunity awaits you!
MoonLake is a dynamic and innovative company pushing the boundaries of possibility, and we are looking for passionate individuals to join our stellar team.
An opportunity to learn and grow alongside experienced professionals in a supportive and innovative biotech environment.
Contribute to ground-breaking projects that have the potential to transform global healthcare.
Enjoy a healthy work-life balance while making meaningful contributions to our team.
A clear path for career progression, with the chance to take on more responsibilities as you develop your skills.
MoonLake is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody® for the treatment of the inflammatory disease, to revolutionize outcomes for patients.
We continue to make significant progress in our Global Clinical Development Programs. The company’s focus is on inflammatory diseases with a major unmet need, including hidradenitis suppurativa and psoriatic arthritis – conditions affecting millions of people worldwide with a large need for improved treatment options. MoonLake was founded in 2021 and is headquarted in Zug, with hubs in Cambridge & Porto.
Further information is available at www.moonlaketx.com